Maria Moccia


Benedetta Carrozzini

Maria Moccia
Tel: +39 06 90672 676
E-mail: -
Address: Via G.Amendola 122/O 70126, Bari, Italy





Present position :

- Staff Researcher


Short CV :

2003: MSc Organic Chemistry, University of Naples.
2007: PhD Organic Chemistry under the supervision of Prof. C. Pedone, Department of Biological Science, University of Naples. During PhD worked at Edinburgh University under the supervision of Prof Mark Bradley on "Non enzymatic method for single nucleotide polymorphism analysis".

2008: Post-doctoral Research Fellows at IBB-CNR on project entitled "Peptide-PNA chimera mimetic of Ni superoxide dismutase (SOD) binding site".
2009-2011: Awarded Marie Curie fellowship (CEMP) : Development of novel PNA based molecular probes for the detection of c-Myc mRNA.
2011-2012: Senior Post-doctoral Research Fellow in Chemistry at RCSI founded by TIDA and SFI.
2013-nowdays: Researcher at IC-CNR


Research Interests :

Design, synthesis and development of peptide nucleic acid as miRNA mimics for therapeutic applications.

Peptide synthesis, oligonucleotide synthesis DNA, PNA, DNA/PNA chimera

Development of Diversity Oriented Synthesis using sugar (d-deoxy ribose) based polyfunctional scaffolds.

Asymmetric Organocatalysis: bifunctional and phase transfer catalysis (PTC ) to design new synthetic strategies  to obtain active pharmaceutical ingredients (API)

Direct sulfonylation of activated olefins.


Projects :
Fondazione con il SUD-Bando Sviluppo del Capitale Umano ad alta Qualificazione 2011.
2011-DPR-20; Titolo "Verso la medicina personalizzata: Sviluppo di nuove molecole selettive perla cura del Neuroblastoma".
The aim of the project was the design, synthesis and biological assessment of novel PNA-34a molecules for the treatment of Neuroblastoma.

Project Coordinator of H2020-MSCA-RISE-2014-645317- Chemo-enzymatic Manufacturing routes to high value compounds (ChemoEnz).  01/06/2015-31/05/2017
The aim of this project is to bring together subject matter experts from the academic and non-academic sectors to develop a platform of "green" chemoenzymatic methods for the production of high value active pharmaceutical ingredients – both those currently on the market, and those in development pipelines of the Pharma industry. The partners will exemplify the use of the platform through its application in the production of 4 drugs currently on the market – namely Duloxetine, Atomexetine, Ramosetron and Paricalcitol. In order to achieve this objective the proposal brings together 3 partners with complementary skills:
IC-CNR: Protein crystallography, organo catalysis; Kelada Pharmachem: Phase transfer catalysis/organo catalysis/scale-up of chemical processes Cerbios Pharma: Biocatalysis and fermentation methodologies for drug production.
Other information about the project:


Selected publications :

1. Moccia M., Adamo MFA, Saviano M., Insights on chiral, backbone modified peptide nucleic acids: Properties and biological activity 2016, . 5 (3), e1107176, pp. 1-15.


2. Adamo MFA , Kelly B., Moccia M.,Recent advances in the preparation of active pharmaceutical ingredient (S)-Pregabalin. Chemistry Today 2016, 34, 54-57.


3. Del Fiandra, C., Moccia, M.; Adamo, M.F.A.* Enantioselective cyclopropanation of (Z)-3-substituted-2-(4-pyridyl)-acrylonitriles catalyzed by cinchona ammonium salts. Org. Biomol. Chem., 2016, 14(11), 3105-3111.


4. Del Fiandra, C., Moccia, M.; Cerulli, V.; Adamo, M.F.A.* Catalytic asymmetric conjugate addition  of  isocyanoacetate to (Z)-3-substituted-2-(4-pyridyl)-acrylonitrile, a reactive class of Michael acceptor. Chem. Commun, 2016, 52 , 1697-1700.


5. Disetti, P., Moccia, M., Salazar-Illera D., Suresh S., Adamo M. F.A* Catalytic enantioselective addition of isocyanoacetate to 3-methyl-4nitro-5-styrilisoxazoles under phase transfer catalysis conditions. Org. Biomol. Chem., 2015,13, 10609-10612.


6. Moccia, M.,*Cortigiani, M., Monasterolo, C., Torri, F., Del Fiandra, C., Fuller, G., Kelly, B., Adamo, M.F.A. * Development and scale up of an organocatalytic enantioselective process to manufacture (S)-Pregabalin. Org. Pro. Res. Dev. 2015, 19(9) 1274-1281.


7. Moccia, M.,* Wells, R. J., Adamo, M.F.A.,* An improved procedure to prepare 3-methyl-4-nitroalkenethylisoxazoles and their reaction under catalytic enantioselective Michael addition with nitromethane. Org. Biomol. Chem.2015,  13, 2192-2195.


8. Piras, L., Moccia, M., Cortigiani, M., Adamo, M.F.A.*,. Cyclopropanation of 5-(1-bromo-2-phenyl-vinyl)-3-methyl-4-nitro-isoxazoles under phase transfer catalysis (PTC) conditions. Catalysts, 2015,5(2), 595-605.


9.Del Fiandra C, Piras L, Fini F, Disetti P, Moccia M, Adamo MFA. Phase transfer catalyzed enantioselective cyclopropanation 4-nitro-5-styrylisoxazoles. Chem. Commun. 2012, 48, 3863-5.


10. Salazar Illera D, Suresh S, Moccia M, Bellini G, Saviano M, Adamo MFA. N-Heterocyclic carbene catalysed homoenolate addition to 3-methyl-4-nitro-5-styrylisoxazoles. Tetrahedron Lett., 2012, 53, 1808-11.


11. Moccia M, Fini F, Scagnetti M, Adamo M F.A. Catalytic enantioselective addition of sodium bisulfite to chalcones. Angew. Chem. Int. Ed. 2011, 50, 6893-6895.


12. Bruschi S, Moccia M, Mauro MFA. Studies on the reactivity of 3-methyl-4-nitro-5-styrylisoxazoles with S-Nucleophiles. Tetrahedron Lett., 2011, 52, 3602-3604.


13. Musumeci D, Bucci E, Roviello GN, Sapio R, Valente M, Moccia M, Bianchi ME, Pedone C. DNA-based strategies for blocking HMGB1 cytokine activity: design, synthesis and preliminary in vitro/in vivo assays of DNA and DNA-like duplexes. Mol. Biosyst., 2011, 7, 1742-52.


14. Adamo FMA, Pergoli R, Moccia M. Alkynyl 2-deoxy-D-riboses,  a cornucopia for generation of families of C-nucleosides. Tetrahedron, 2010, 66, 9242-9251.


15. Moccia M, Roviello GM, Bucci EM, Pedone C, Saviano M.  Synthesis of a L-lysine-based alternate alpha,epsilon-peptide: a novel linear polycation with nucleic acid-binding ability. Int.J. Pharm, 2010, 397, 179-83.


Last Updated (Thursday, 27 April 2017 13:02)